Publications by authors named "Neil Rabin"

Claim this Profile
N
NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma.
Gaurav Agarwal, Mohammad Kazeroun, Mirian Salazar, Khrystal McBean, Ananya Kannan, Neil Rabin

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT.
Simona Iacobelli, Stefan Schönland, Linda Koster, Didier Blaise, Emma Nicholson, Neil Rabin

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Radiotherapy for Patients With Multiple Myeloma in the Modern Era: A Real World Single-Centre Experience.
Dipal Mehta, Maria Gabriel, Nathan Adu-Poku, Nikolaos Kanellias, Xenofon Papanikolaou, Neil Rabin

EJHaem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current quality of life questionnaires are not relevant for assessing QOL issues in multiple myeloma patients in the era of modern therapies: results from a survey with myeloma patients and myeloma healthcare professionals.
Catherine S Y Lecat, Sotirios Bristogiannis, Dipal Mehta, Yadanar Lwin, Joanne Land, Neil K Rabin

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single-center, real-world experience.
Ke Xu, Charles Agbuduwe, Nickolaos Kanellias, William Wilson, Annabel McMillan, Neil Rabin

Haematologica· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Attribution of Value Framework for Combination Treatments.
Andrew H Briggs, Alexis Doyle-Connolly, John Schneider, Tanja Podkonjak, Helen Taylor, Neil Rabin

Value Health· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of physiotherapist-led exercise prehabilitation and rehabilitation during autologous stem cell transplantation in myeloma: a single-centre experience.
Joanne Land, Michael K Luong, Alasdair Longden, Neil Rabin, Charalampia Kyriakou

BMJ Open Qual· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper.
Martin Kaiser, Vicky Goh, Simon Stern, Nicholas Spencer, Neil Rabin

Br J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of melphalan 140 mg/m followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience.
Dario Melotti, Samir Asher, Ethan Troy-Barnes, George Nesr, William Wilson, Neil Rabin

EJHaem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma.
Ke Xu, Eleanor Kaffo, Robert Baker, Elisabeth Nacheva, Annabel McMillan, Neil Rabin

EJHaem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of continuous lenalidomide maintenance treatment on people living with multiple myeloma-a single-centre, qualitative service evaluation study.
Caroline Buck, Francisco Brenes Castillo, Elena Bettio, Joanne Land, Orla McCourt, Neil Rabin

Support Care Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper.
Daniel Hughes, Kwee Yong, Karthik Ramasamy, Simon Stern, Eileen Boyle, Neil Rabin

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.
George Nesr, Raakhee Shah, Charalampia Kyriakou, Jonathan Sive, Rakesh Popat, Neil Rabin

Leuk Lymphoma· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT.
Rémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, Nienke Zinger, Mathias Haenel, Neil Rabin

Bone Marrow Transplant· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Neil K Rabin

Bone Marrow Transplant· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and psychological impact of minimal residual disease assessment on patients with multiple myeloma.
Nuno Correia, Emma Dowling, Rakesh Popat, Neil Rabin, Chara Kyriakou

Br J Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Neil K Rabin

Bone Marrow Transplant· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise prehabilitation for people with myeloma undergoing autologous stem cell transplantation: results from PERCEPT pilot randomised controlled trial.
Orla McCourt, Abigail Fisher, Gita Ramdharry, Joanne Land, Anna L Roberts, Neil Rabin

Acta Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial.
Meletios A Dimopoulos, Albert Oriol, Hareth Nahi, Jesus San-Miguel, Nizar J Bahlis, Neil Rabin

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providers.
Gordon Cook, John Ashcroft, Mariana Fernandez, Sarah Henshaw, Zeyad Khalaf, Neil Rabin

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma.
Samir Asher, Aikaterini Kazantzi, Fatjon Dekaj, Luke Steventon, Aisha Khatun, Neil Rabin

Haematologica· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination.
Lara Howells, Wei Yee Chan, Emilie Sanchez, Jacqueline Horder, Fiona Newrick, Neil Rabin

Leuk Lymphoma· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study.
Marquita Camilleri, Georgios Bekris, Govundeep Sidhu, Caroline Buck, Esma Elsden, Neil Rabin

Support Care Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Jahanzaib Khwaja, Joshua Bomsztyk, Shameem Mahmood, Brendan Wisniowski, Raakhee Shah, Neil Rabin

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
railty-adjusted therapy n ransplant on-ligible patient with newly diagnoed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial.
Amy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, David A Cairns, Anna Hockaday, Neil Rabin

BMJ Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis